Lisa Conroy

Lisa Conroy is the Director of Communications at Antidote. She is a seasoned health communications strategist dedicated to understanding the reasons people make the health choices they do, and determining what that means in terms of how scientific data should be communicated. Prior to her role at Antidote, Lisa ran the TEDMED Great Challenges program, a public health initiative funded by RWJF. She also has experience working in pharmaceutical public relations in the areas of respiratory diseases, oncology, and HIV. Lisa holds an MPH from Columbia and a BA in English and International Studies from Northwestern.

Pre-Recruitment Research: The Groundwork for Precision Recruitment

Antidote recently conducted a survey with SCORR Marketing through which we asked nearly 4,000 patients about their perspectives on clinical trials. One key finding: patients with different conditions have different opinions on taking part in medical research. For example, in the survey, people with melanoma were joining clinical trials to extend their own lives, while those with lupus or kidney ...

Continue reading

Webinar: Precision Recruitment for Faster and More Patient-Centric Recruitment

Last week we distributed a white paper on precision recruitment, a new approach that not only speeds up clinical trial recruitment, but also provides a better patient experience throughout the recruitment process. Now, we're inviting you to join a webinar on March 28th at 12pm, during which we will be diving deeper into this topic.

Continue reading

Precision Recruitment: An Innovative Approach to Faster and More Patient-Centric Trial Recruitment [White Paper]

With medicine getting ever more targeted and precise, clinical trial protocols are becoming more complex than ever before. While this allows for appropriate evaluation of potential treatment options, it also means that finding patients to take part in trials is increasingly challenging, and the need to look beyond traditional methods of recruitment has become clear.

Continue reading

SCOPE Summit: Reflections on Empathy

There are conferences we attend to connect with clients. There are conferences we attend to build partnerships. At SCOPE, we are able to do both. The SCOPE Summit convenes the best, the brightest, and the most dedicated in the clinical trial operations space with one aim: to accelerate clinical research. This is why we go to SCOPE.

Continue reading

Will We See You at the SCOPE Summit?

Once a year, we head to Orlando to collaborate with and learn from some of the best and brightest minds in clinical trial operations. That’s right: we’re attending the SCOPE Summit next week.

Continue reading

Introducing Our Newest Partner: PWNHealth

It's with great excitement that we share that we have officially partnered with PWNHealth, a virtual care company that enables patient access to diagnostic testing, treatment, and professional guidance, to bolster efficiencies in our clinical trial recruitment by incorporating direct-to-patient lab services.

Continue reading

Introducing Our Newest Recruitment Partner: phaware global association®

We’re pleased to share that we have officially partnered with phaware®, an advocacy organization comprised of patients, caregivers, and medical professionals who are dedicated to creating global pulmonary hypertension (PH) awareness, to provide end-to-end patient recruitment services to pharmaceutical companies and CROs running trials in chronic lung diseases.

Continue reading

Announcing Our Newest Partner: the Lupus Foundation of America

We know that life with lupus can be difficult at times. And while there's no cure, there is hope: through medical research, we can improve the lives of people living with or affected by lupus — and maybe one day, find a cure.

Continue reading

Minorities in Clinical Trials: Why Study Populations Need to Match Real-World Ones

Every drug that is on the market today went through clinical trials before it could hit pharmacy shelves. These trials are a way for researchers to evaluate whether new drugs or potential treatments work and are safe for the people living with the condition they are meant to treat. The importance of this research cannot be overstated — but there's a problem. Patients need to take part in clinical ...

Continue reading

Get our latest posts in your inbox.